DNA damage response in peripheral nervous system

Coping with cancer therapy-induced DNA lesions

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

In the absence of blood brain barrier (BBB) the DNA of peripheral nervous system (PNS) neurons is exposed to a broader spectrum of endogenous and exogenous threats compared to that of the central nervous system (CNS). Hence, while CNS and PNS neurons cope with many similar challenges inherent to their high oxygen consumption and vigorous metabolism, PNS neurons are also exposed to circulating toxins and inflammatory mediators due to relative permeability of PNS blood nerve barrier (BNB). Consequently, genomes of PNS neurons incur greater damage and the question awaiting investigation is whether specialized repair mechanisms for maintenance of DNA integrity have evolved to meet the additional needs of PNS neurons. Here, I review data showing how PNS neurons manage collateral DNA damage incurred in the course of different anti-cancer treatments designed to block DNA replication in proliferating tumor cells. Importantly, while PNS neurotoxicity and concomitant chemotherapy-induced peripheral neuropathy (CIPN) are among major dose limiting barriers in achieving therapy goals, CIPN is partially reversible during post-treatment nerve recovery. Clearly, cell recovery necessitates mobilization of the DNA damage response and underscores the need for systematic investigation of the scope of DNA repair capacities in the PNS to help predict post-treatment risks to recovering neurons.

Original languageEnglish (US)
Pages (from-to)685-690
Number of pages6
JournalDNA Repair
Volume12
Issue number8
DOIs
StatePublished - Aug 2013

Fingerprint

Peripheral Nervous System
Neurology
Genetic Therapy
DNA Damage
Neurons
DNA
Neoplasms
Peripheral Nervous System Diseases
Chemotherapy
Blood-Nerve Barrier
Central Nervous System
Repair
Drug Therapy
Recovery
Therapeutics
Blood-Brain Barrier
DNA Replication
Oncology
Oxygen Consumption
DNA Repair

Keywords

  • Base excision repair (BER)
  • Blood brain barrier (BBB)
  • Blood nerve barrier (BNB)
  • Chemotherapy-induced peripheral neuropathy (CIPN)
  • Cisplatin cross-links
  • Cytosine arabinoside (ara-C)
  • Dorsal root ganglion (DRG)
  • Ionizing radiation (IR)
  • Nucleotide excision repair (NER)
  • Peripheral nervous system (PNS)

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

DNA damage response in peripheral nervous system : Coping with cancer therapy-induced DNA lesions. / Englander, Ella.

In: DNA Repair, Vol. 12, No. 8, 08.2013, p. 685-690.

Research output: Contribution to journalArticle

@article{c5dba68d80b0404cac2db5f7b0118a6a,
title = "DNA damage response in peripheral nervous system: Coping with cancer therapy-induced DNA lesions",
abstract = "In the absence of blood brain barrier (BBB) the DNA of peripheral nervous system (PNS) neurons is exposed to a broader spectrum of endogenous and exogenous threats compared to that of the central nervous system (CNS). Hence, while CNS and PNS neurons cope with many similar challenges inherent to their high oxygen consumption and vigorous metabolism, PNS neurons are also exposed to circulating toxins and inflammatory mediators due to relative permeability of PNS blood nerve barrier (BNB). Consequently, genomes of PNS neurons incur greater damage and the question awaiting investigation is whether specialized repair mechanisms for maintenance of DNA integrity have evolved to meet the additional needs of PNS neurons. Here, I review data showing how PNS neurons manage collateral DNA damage incurred in the course of different anti-cancer treatments designed to block DNA replication in proliferating tumor cells. Importantly, while PNS neurotoxicity and concomitant chemotherapy-induced peripheral neuropathy (CIPN) are among major dose limiting barriers in achieving therapy goals, CIPN is partially reversible during post-treatment nerve recovery. Clearly, cell recovery necessitates mobilization of the DNA damage response and underscores the need for systematic investigation of the scope of DNA repair capacities in the PNS to help predict post-treatment risks to recovering neurons.",
keywords = "Base excision repair (BER), Blood brain barrier (BBB), Blood nerve barrier (BNB), Chemotherapy-induced peripheral neuropathy (CIPN), Cisplatin cross-links, Cytosine arabinoside (ara-C), Dorsal root ganglion (DRG), Ionizing radiation (IR), Nucleotide excision repair (NER), Peripheral nervous system (PNS)",
author = "Ella Englander",
year = "2013",
month = "8",
doi = "10.1016/j.dnarep.2013.04.020",
language = "English (US)",
volume = "12",
pages = "685--690",
journal = "DNA Repair",
issn = "1568-7864",
publisher = "Elsevier",
number = "8",

}

TY - JOUR

T1 - DNA damage response in peripheral nervous system

T2 - Coping with cancer therapy-induced DNA lesions

AU - Englander, Ella

PY - 2013/8

Y1 - 2013/8

N2 - In the absence of blood brain barrier (BBB) the DNA of peripheral nervous system (PNS) neurons is exposed to a broader spectrum of endogenous and exogenous threats compared to that of the central nervous system (CNS). Hence, while CNS and PNS neurons cope with many similar challenges inherent to their high oxygen consumption and vigorous metabolism, PNS neurons are also exposed to circulating toxins and inflammatory mediators due to relative permeability of PNS blood nerve barrier (BNB). Consequently, genomes of PNS neurons incur greater damage and the question awaiting investigation is whether specialized repair mechanisms for maintenance of DNA integrity have evolved to meet the additional needs of PNS neurons. Here, I review data showing how PNS neurons manage collateral DNA damage incurred in the course of different anti-cancer treatments designed to block DNA replication in proliferating tumor cells. Importantly, while PNS neurotoxicity and concomitant chemotherapy-induced peripheral neuropathy (CIPN) are among major dose limiting barriers in achieving therapy goals, CIPN is partially reversible during post-treatment nerve recovery. Clearly, cell recovery necessitates mobilization of the DNA damage response and underscores the need for systematic investigation of the scope of DNA repair capacities in the PNS to help predict post-treatment risks to recovering neurons.

AB - In the absence of blood brain barrier (BBB) the DNA of peripheral nervous system (PNS) neurons is exposed to a broader spectrum of endogenous and exogenous threats compared to that of the central nervous system (CNS). Hence, while CNS and PNS neurons cope with many similar challenges inherent to their high oxygen consumption and vigorous metabolism, PNS neurons are also exposed to circulating toxins and inflammatory mediators due to relative permeability of PNS blood nerve barrier (BNB). Consequently, genomes of PNS neurons incur greater damage and the question awaiting investigation is whether specialized repair mechanisms for maintenance of DNA integrity have evolved to meet the additional needs of PNS neurons. Here, I review data showing how PNS neurons manage collateral DNA damage incurred in the course of different anti-cancer treatments designed to block DNA replication in proliferating tumor cells. Importantly, while PNS neurotoxicity and concomitant chemotherapy-induced peripheral neuropathy (CIPN) are among major dose limiting barriers in achieving therapy goals, CIPN is partially reversible during post-treatment nerve recovery. Clearly, cell recovery necessitates mobilization of the DNA damage response and underscores the need for systematic investigation of the scope of DNA repair capacities in the PNS to help predict post-treatment risks to recovering neurons.

KW - Base excision repair (BER)

KW - Blood brain barrier (BBB)

KW - Blood nerve barrier (BNB)

KW - Chemotherapy-induced peripheral neuropathy (CIPN)

KW - Cisplatin cross-links

KW - Cytosine arabinoside (ara-C)

KW - Dorsal root ganglion (DRG)

KW - Ionizing radiation (IR)

KW - Nucleotide excision repair (NER)

KW - Peripheral nervous system (PNS)

UR - http://www.scopus.com/inward/record.url?scp=84880607469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880607469&partnerID=8YFLogxK

U2 - 10.1016/j.dnarep.2013.04.020

DO - 10.1016/j.dnarep.2013.04.020

M3 - Article

VL - 12

SP - 685

EP - 690

JO - DNA Repair

JF - DNA Repair

SN - 1568-7864

IS - 8

ER -